News Sentiment

ORMP sentiment intelligence

Oramed Pharmaceuticals Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 51 Balanced news tone 23 relevant articles
Exchange TLV Israel
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1135.00 Week of 19 Jun 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

88/100 classification confidence.

Company focus 23

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+2.1% over one week, -9.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

ORMP SEC Filings - Oramed Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 88/100 classification
One-week reaction 2.1% Price confirming higher
Trend fit Trend active -9.1% over four weeks
Fair value 1949.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 22
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 23
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 5
TradingKey 4
Seeking Alpha 2
PR Newswire 2
simplywall.st 2
GuruFocus 1
Investing.com Canada 1
AD HOC NEWS 1

Event Lens

What the news is about

Classified themes
Market update 18
Deals and strategy 2
Capital return 1
Earnings 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-23 of 23